High Clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.

CONCLUSIONS: High CLU mRNA levels in CRC tumors can act as a new adverse prognostic biomarker of DFS and OS for CRC, independent of clinicopathological and biological features of the patient.
PMID: 31672651 [PubMed - as supplied by publisher]

Source: Clinical Biochemistry - October 27, 2019 Category: Biochemistry Authors: Artemaki PI, Sklirou AD, Kontos CK, Liosi AA, Gianniou DD, Papadopoulos IN, Trougakos IP, Scorilas A Tags: Clin Biochem Source Type: research